Enanta Pharmaceuticals
ENTA
#7630
Rank
NZ$0.66 B
Marketcap
NZ$23.09
Share price
1.36%
Change (1 day)
174.57%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2025 (TTM): NZ-$6.63

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$6.58. In 2024 the company made an earnings per share (EPS) of NZ-$8.51.

EPS history for Enanta Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.63-22.11%
2024NZ-$8.51
2021NZ-$8.5672.92%
2020NZ-$4.95-267.44%
2019NZ$2.96-61.35%
2018NZ$7.65147.22%
2017NZ$3.09-460%
2016NZ-$0.86-114.88%
2015NZ$5.78-23.81%
2014NZ$7.58-244.12%
2013NZ-$5.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.15-390.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.38-287.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$4.11-162.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$26.59-503.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.57-290.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.95-190.34%๐Ÿ‡บ๐Ÿ‡ธ USA